Busulfan [clinicaltrials_resource:6036f5bbcac4a9e6ad5bd2d4d3c2d98a]
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002502]Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse [clinicaltrials:NCT00002554]clinicaltrials:NCT00002831Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002961]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]clinicaltrials:NCT00003116Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors [clinicaltrials:NCT00003462]clinicaltrials:NCT00003816Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003875]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer [clinicaltrials:NCT00003972]clinicaltrials:NCT00004088Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004896]clinicaltrials:NCT00005866Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005948]Busulfan in Treating Children and Adolescents With Refractory CNS Cancer [clinicaltrials:NCT00006246]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00027924]clinicaltrials:NCT00049517Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder [clinicaltrials:NCT00054340]clinicaltrials:NCT00070135Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [clinicaltrials:NCT00084695]Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant [clinicaltrials:NCT00092937]clinicaltrials:NCT00113919Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer [clinicaltrials:NCT00134017]Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [clinicaltrials:NCT00152126]Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study [clinicaltrials:NCT00156858]Preference Study With Elderly Patients Recurrent Ovarian Cancer [clinicaltrials:NCT00170690]clinicaltrials:NCT00176839clinicaltrials:NCT00176852clinicaltrials:NCT00176930Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies [clinicaltrials:NCT00208923]IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency [clinicaltrials:NCT00228852]clinicaltrials:NCT00238433clinicaltrials:NCT00245037clinicaltrials:NCT00258427clinicaltrials:NCT00281879
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Busulfan [clinicaltrials_resource:6036f5bbcac4a9e6ad5bd2d4d3c2d98a]
Bio2RDF identifier
6036f5bbcac4a9e6ad5bd2d4d3c2d98a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6036f5bbcac4a9e6ad5bd2d4d3c2d98a
identifier
clinicaltrials_resource:6036f5bbcac4a9e6ad5bd2d4d3c2d98a
title
Busulfan
@en
type
label
Busulfan [clinicaltrials_resource:6036f5bbcac4a9e6ad5bd2d4d3c2d98a]
@en